Understanding gene regulation has become essential to modern drug discovery. While DNA sequence and RNA expression provide valuable information, they reveal only part of the story. Epigenomic technologies, particularly chromatin mapping assays like CUT&RUN, are enabling researchers to investigate the regulatory mechanisms that control gene expression, offering a level of insight that transcriptional profiling alone cannot provide.
Introduction
In this GEN eBook, How Epigenomics is Transforming Drug Discovery and Development, readers will discover how epigenomic insights are improving every stage of the drug discovery pipeline, from target identification and validation to mechanism-of-action studies and therapeutic optimization.
Read this eBook to learn:
- Why understanding gene regulation matters in drug discovery and development
- How epigenomic profiling is being used to identify novel therapeutic targets, elucidate drug mechanisms of action, investigate treatment resistance, and support development of emerging modalities such as targeted protein degraders (e.g. PROTACs, molecular glues)
- How next-generation technologies, including CUT&RUN, are providing unprecedented insights into gene regulation
Through expert perspectives and real-world case studies, this eBook demonstrates how researchers are applying epigenomic approaches to answer critical biological questions, characterize therapeutic responses, and make more informed decisions throughout drug development.
Whether you’re working in target discovery, translational research, or therapeutic development, this eBook provides a practical overview of the technologies and strategies that are reshaping modern drug discovery.
Read this eBook to learn how CUT&RUN and related epigenomic tools are helping pharmaceutical and biotechnology researchers uncover disease mechanisms, identify high-confidence drug targets, and accelerate the development of more effective therapies.